Skip to main content

Nanoparticle design and manufacturing in cancer nanotechnology: challenges of drug delivery, targeted treatment and selective detection

Edited by Željka Krpetić (University of Salford, UK)

Nanoparticle design is one of the fastest growing fields of applied science. Purposely designing and manufacturing nanoparticles for cancer nanotechnology applications is promising due to the reduced side effects nanoparticles have in diagnostics and treatment of cancer. Challenges arise when tackling the parameters that play a key role for targeting of specific tumours and managing to overcome the effects that may create obstacles when working in realistic biological environments. 
Moreover, since nanomaterials destined for clinical use and nanomedicine, in general, require special attention, novel approaches for nanoparticle manufacturing, handling and characterisation are required to minimise the risks associated with contamination, and address the questions of nanoparticle administration, incorrect dosing of the nanoparticles directly relating to the challenges in current nanoparticle characterisation.
This special collection in Cancer Nanotechnology provides a collection of original research papers and expert reviews that cover a range of approaches in the field of nanofabrication and/or advanced nanoparticle characterisation that show advancement in design of nano-based tools for drug delivery, targeted treatment and selective detection of cancer.

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cancer Nanotechnology.

New articles in the collection will be added here as they are published.

  1. Fluorescent silica nanoparticles have been extensively utilised in a broad range of biological applications and are facilitated by their predictable, well-understood, flexible chemistry and apparent biocompati...

    Authors: Vladimir Gubala, Giorgia Giovannini, Filip Kunc, Marco P. Monopoli and Colin J. Moore

    Citation: Cancer Nanotechnology 2020 11:1

    Content type: Review

    Published on:

  2. Chemotherapeutic agents have limited efficacy and resistance to them limits today and will limit tomorrow our capabilities of cure. Resistance to treatment with anticancer drugs results from a variety of facto...

    Authors: Eudald Casals, Muriel F. Gusta, Macarena Cobaleda-Siles, Ana Garcia-Sanz and Victor F. Puntes

    Citation: Cancer Nanotechnology 2017 8:7

    Content type: Review

    Published on:

  3. Early diagnosis, monitoring and treatment selection of cancer represent major challenges in medicine. The definition of the complex clinical and molecular landscape of cancer requires the combination of multip...

    Authors: Luca Guerrini, Nicolas Pazos-Perez, Eduardo Garcia-Rico and Ramon Alvarez-Puebla

    Citation: Cancer Nanotechnology 2017 8:5

    Content type: Review

    Published on: